Fig. 3From: Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndromeChanges in fasting insulin and HOMA-IR between the early treatment group (shaded) and later treatment group (blank) from baseline to 4 years old. The lower and upper bounds are the 25th percentile and the 75th percentile, respectively. The horizontal line in the box shows the median. #, P < 0.05, compared with the later treatment groupBack to article page